RCUS - Arcus Biosciences - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RCUS is currently covered by 7 analysts with an average price target of $40.05. This is a potential upside of $19.04 (90.62%) from yesterday's end of day stock price of $21.01.

Arcus Biosciences's activity chart (see below) currently has 124 price targets and 107 ratings on display. The stock rating distribution of RCUS is 68.75% BUY and 31.25% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 40.79% with an average time for these price targets to be met of 234.13 days.

Highest price target for RCUS is $56, Lowest price target is $14, average price target is $28.14.

Most recent stock forecast was given by TERENCE FLYNN from MORGAN STANLEY on 08-Jan-2026. First documented stock forecast 09-Apr-2018.

Currently out of the existing stock ratings of RCUS, 11 are a BUY (68.75%), 5 are a HOLD (31.25%).

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

Since 11-Oct-2022

$20

$-1.01 (-4.81%)

$22

3 days ago
(08-Jan-2026)

3/9 (33.33%)

$-3.2 (-13.79%)

248

Buy

Since 26-Feb-2025

$32

$10.99 (52.31%)

$28

30 days ago
(12-Dec-2025)

4/6 (66.67%)

$6.86 (27.29%)

312

Hold

Since 18-Nov-2022

$26

$4.99 (23.75%)

$17

1 months 14 days ago
(28-Nov-2025)

5/5 (100%)

$0.44 (1.72%)

218

Hold

Since 09-Apr-2018

$16

$-5.01 (-23.85%)

$13

2 months 12 days ago
(30-Oct-2025)

2/4 (50%)

$-4.19 (-20.75%)

420

Buy

Since 24-May-2019

$56

$34.99 (166.54%)

$54

2 months 13 days ago
(29-Oct-2025)

2/13 (15.38%)

$35.71 (176.00%)

294

Show more analysts

Please expand the browser size to see the chart

What is RCUS (Arcus Biosciences) average time for price targets to be met?

On average it took 234.13 days on average for the stock forecasts to be realized with a an average price target met ratio 40.79

Which analyst has the current highest performing score on RCUS (Arcus Biosciences) with a proven track record?

ROBERT DRISCOLL

Which analyst has the most public recommendations on RCUS (Arcus Biosciences)?

Robert Driscoll works at WEDBUSH and has 17 price targets and 10 ratings on RCUS

Which analyst is the currently most bullish on RCUS (Arcus Biosciences)?

Kaveri Pohlman with highest potential upside - $50.9

Which analyst is the currently most reserved on RCUS (Arcus Biosciences)?

Peter Lawson with lowest potential downside - -$7.01

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?